AAN

Vitamin E Tocotrienols May Protect Against Stroke
April 15, 2014

Mixed tocotrienols are effective in attenuating the progression of white matter lesions in humans, the results of a new study have shown.

To Prevent a Second Stroke, Lower Blood Pressure to Normal
April 08, 2014

All patients with stroke should have their blood pressure lowered to normal levels, a new study shows.

"Doc, I Think I Have Carpal Tunnel…"
March 27, 2014

Progressive numbness in 3 fingers on both hands led this computer programmer to diagnose himself as having carpal tunnel syndrome. But, there's more to this story.

Survival in ALS Plus FTD Influenced by Timing of Symptom Onset
May 02, 2009

What is the prognosis for patients with frontotemporal dementia and motor neuron disease? A new study suggests the answer depends not on which occurs first, but whether cognitive and motor symptoms develop simultaneously.

Improved Acute Ischemic Stroke Outcomes With tPA
May 02, 2009

An analysis of 1274 patients with acute ischemic stroke (AIS) admitted to a single Colorado medical center over a 2-year period found that application of any acute stroke treatment strategy improved the patients’ NIH Stroke Scale (NIHSS) score.

Orthostatic Hypotension Increases the Risk of Alzheimer Disease
May 02, 2009

Alzheimer disease (AD) is more than twice as likely to develop in elderly persons with orthostatic hypotension (OH) as in those without OH, according to a new study presented at the Annual Meeting of the American Academy of Neurology.

Chronic Migraine Patients Also Burdened With Higher Medical Costs
May 01, 2009

The total direct and indirect costs for treating patients with chronic migraines (CM) are 2.6 times higher than costs associated with episodic migraine (EM). Containing those costs through better management of the illness should be a priority, according to migraine researchers who led a nationwide study comparing the costs of CM and EM as part of the American Migraine Prevalence and Prevention (AMPP) Study.

Adding Corticosteroid to MS Regimen May Reduce Disease Activity
April 30, 2009

The addition of methylprednisolone to interferon ß (IFN-ß) therapy may reduce disease activity in patients with multiple sclerosis (MS) to a greater degree than treatment with IFN-ß alone. “These results indicate that these 2 drugs may have a synergy when taken together and provide a more beneficial effect on the disease activity,” said study author Mads Ravnborg, MD, of the Danish Multiple Sclerosis Research Center at Copenhagen University Hospital in Denmark.